MedPath

Daunorubicin Hydrochloride

DAUNORUBICIN HYDROCHLORIDE INJECTION Rx ONLY

Approved
Approval ID

9705fa12-499e-41a3-8fb4-f6df0858b851

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 9, 2021

Manufacturers
FDA

Hisun Pharmaceuticals USA, Inc.

DUNS: 961628505

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

daunorubicin hydrochloride

PRODUCT DETAILS

NDC Product Code42658-019
Application NumberANDA208759
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateFebruary 9, 2021
Generic Namedaunorubicin hydrochloride

INGREDIENTS (5)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
DAUNORUBICIN HYDROCHLORIDEActive
Quantity: 5 mg in 1 mL
Code: UD984I04LZ
Classification: ACTIM

daunorubicin hydrochloride

PRODUCT DETAILS

NDC Product Code42658-021
Application NumberANDA208759
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateFebruary 9, 2021
Generic Namedaunorubicin hydrochloride

INGREDIENTS (5)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
DAUNORUBICIN HYDROCHLORIDEActive
Quantity: 5 mg in 1 mL
Code: UD984I04LZ
Classification: ACTIM
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Daunorubicin Hydrochloride - FDA Approval | MedPath